Dalbavancin: Revision history

7 April 2021

• curprev 20:0920:09, 7 April 2021‎ Elcatracho talk contribs‎ 1,960 bytes +29‎ →‎See Also
• curprev 20:0820:08, 7 April 2021‎ Elcatracho talk contribs‎ 1,931 bytes +30‎ →‎See Also
• curprev 20:0620:06, 7 April 2021‎ Elcatracho talk contribs‎ 1,901 bytes 0‎ →‎See Also
• curprev 20:0620:06, 7 April 2021‎ Elcatracho talk contribs‎ 1,901 bytes +23‎ →‎See Also
• curprev 07:4907:49, 7 April 2021‎ Elcatracho talk contribs‎ 1,878 bytes +8‎ →‎Pharmacology
• curprev 07:4807:48, 7 April 2021‎ Elcatracho talk contribs‎ 1,870 bytes +24‎ →‎Pharmacology
• curprev 07:4707:47, 7 April 2021‎ Elcatracho talk contribs‎ 1,846 bytes +141‎ →‎Mechanism of Action
• curprev 06:2906:29, 7 April 2021‎ Elcatracho talk contribs‎ 1,705 bytes +162‎ →‎Hepatic Dosing
• curprev 06:2406:24, 7 April 2021‎ Elcatracho talk contribs‎ 1,543 bytes +375‎ →‎Renal Dosing
• curprev 06:2006:20, 7 April 2021‎ Elcatracho talk contribs‎ 1,168 bytes −4‎ →‎Common
• curprev 06:1906:19, 7 April 2021‎ Elcatracho talk contribs‎ 1,172 bytes −2‎ →‎Serious
• curprev 06:1906:19, 7 April 2021‎ Elcatracho talk contribs‎ 1,174 bytes −2‎ →‎Serious
• curprev 06:1906:19, 7 April 2021‎ Elcatracho talk contribs‎ 1,176 bytes −2‎ →‎Serious
• curprev 06:1806:18, 7 April 2021‎ Elcatracho talk contribs‎ 1,178 bytes 0‎ →‎Serious
• curprev 06:1806:18, 7 April 2021‎ Elcatracho talk contribs‎ 1,178 bytes +300‎ →‎Adverse Reactions

• curprev 06:1406:14, 7 April 2021‎ Elcatracho talk contribs‎ 878 bytes +878‎ Created page with "==Administration== *Type: Antibiotic *Dosage Forms: 500 mg/vial; reconstituted concentration 20 mg/ml *Routes of Administration: Intravenous *Common Trade Names: Dalvance..."